Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06134414 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of Safety and Efficacy of MY008211A in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jul 2025 to Jul 2027
    • Start date: Dec 2024 to Dec 2025
    • Study completion date: Dec 2025 to Dec 2027
    v3
  2. Secondary endpoints revised (14)v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The main purpose of this study is to evaluate the efficacy of MY008211A in adult patients with PNH, showing signs of active hemolysis.
Trial Details
NCT Number NCT06134414
Lead Sponsor Wuhan Createrna Science and Technology Co., Ltd
Conditions
(from sponsor)		 Paroxysmal Nocturnal Hemoglobinuria (PNH)
Related terms Hemoglobinuria, Paroxysmal
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov